Enalare Therapeutics Inc. is a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapies for patients suffering from life-threatening acute respiratory and critical care conditions, including respiratory depression caused by drug overdose, post-surgery, and other conditions. The Company is planning to initiate pivotal studies for its lead compound ENA-001 in the near term.

Pharmaceutical

Enalare Therapeutics

Herm Cukier

Alfred Schweikert Ph.D., Rac

Robert Raffa

Marty Lutz

Alfred Schweikert

Joseph Pergolizzi

Frank Diana

Thomas Miller

Daniel Motto

The executive team at Enalare Therapeutics has experience in the pharmaceutical industry, with a focus on commercial strategy and innovation. The team is educated in bioengineering and marketing, with a strong international business background.

CEO and Executive Team

Board of Directors

Leadership Team

CEO and Executive Team

About

Team members

Other teams at Enalare Therapeutics

Board of Directors

Leadership Team